HC
ABBV icon

Hendley & Co’s AbbVie ABBV Stock Holding History

Hendley & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,125
Closed -$274K – 69
2020
Q3 		$274K Buy
+3,125
New +$294K 0.11% 66
2015
Q3 		– Sell
-7,475
Closed -$502K – 62
2015
Q2 		$502K Sell
7,475
-31,711
-81% -$2.07M 0.31% 57
2015
Q1 		$2.29M Sell
39,186
-1,702
-4% -$103K 1.38% 32
2014
Q4 		$2.68M Sell
40,888
-470
-1% -$29.6K 1.73% 21
2014
Q3 		$2.39M Sell
41,358
-34,379
-45% -$1.91M 1.53% 33
2014
Q2 		$4.28M Sell
75,737
-70
-0.1% -$3.67K 2.75% 9
2014
Q1 		$3.9M Sell
75,807
-1,200
-2% -$60.6K 2.74% 9
2013
Q4 		$4.07M Sell
77,007
-15
-0% -$737 2.88% 9
2013
Q3 		$3.44M Sell
77,022
-1,184
-2% -$52.5K 2.86% 7
2013
Q2 		$3.23M Buy
+78,206
New +$3.42M 2.77% 7

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hendley & Co's ABBV Position: Q4 2020 in Review

Hendley & Co sold out of AbbVie (ABBV) in Q4 2020, closing a stake of 3,125 shares — an estimated $274K sold.

Hendley & Co first reported a position in ABBV in Q2 2013 and held it in 10 quarters. The position peaked at $4.28M in Q2 2014. 2,599 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

  • Hendley & Co reported no remaining AbbVie position as of Q4 2020 after selling out during the quarter.
  • Hendley & Co sold 3,125 AbbVie shares in Q4 2020, an estimated $274K.
  • Hendley & Co first reported a position in AbbVie in Q2 2013 and held it in 10 quarters.
  • Hendley & Co's AbbVie position peaked at $4.28M in Q2 2014.
  • 2,599 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on Hendley & Co's 13F filing for Q4 2020, filed 19 Jan 2021.